Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4ld2 | CTN | Cytidine and deoxycytidylate deaminase zinc-binding region |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4ld2 | CTN | Cytidine and deoxycytidylate deaminase zinc-binding region | / | 1.000 | |
4hrq | AZG | Cytidine and deoxycytidylate deaminase zinc-binding region | / | 0.667 | |
4lcn | GNG | Cytidine and deoxycytidylate deaminase zinc-binding region | / | 0.487 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.467 | |
3af1 | GDP | Pantothenate kinase | 2.7.1.33 | 0.466 | |
2a59 | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.460 | |
2cek | N8T | Acetylcholinesterase | 3.1.1.7 | 0.460 | |
3h3r | 14H | Collagen type IV alpha-3-binding protein | / | 0.460 | |
4eso | NAP | Putative oxidoreductase | / | 0.459 | |
3dyl | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.456 | |
3ele | PLP | Aminotransferase | / | 0.455 | |
1h22 | E10 | Acetylcholinesterase | 3.1.1.7 | 0.454 | |
3ryk | TYD | dTDP-4-dehydrorhamnose 3,5-epimerase | / | 0.454 | |
2nmt | MIM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.453 | |
3bxo | UPP | dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucopyranose | / | 0.453 | |
2xuo | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
2a58 | RBF | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.451 | |
3dhk | 23U | Prothrombin | 3.4.21.5 | 0.451 | |
3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.451 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.450 | |
4a2z | VIQ | Glycylpeptide N-tetradecanoyltransferase | / | 0.450 | |
1po7 | TZD | Benzoylformate decarboxylase | 4.1.1.7 | 0.448 | |
2whq | HI6 | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.447 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.446 | |
3gdp | FAD | (R)-mandelonitrile lyase 2 | 4.1.2.10 | 0.446 | |
3hxd | BD7 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.445 | |
1akc | PPE | Aspartate aminotransferase, mitochondrial | 2.6.1.1 | 0.444 | |
1d3d | BZT | Prothrombin | 3.4.21.5 | 0.444 | |
1qti | GNT | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
1u65 | CP0 | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
1ypj | UIB | Prothrombin | 3.4.21.5 | 0.444 | |
2j3q | TFL | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
2o1s | TDP | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | 0.444 | |
3dyl | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.444 | |
3ivc | FG4 | Pantothenate synthetase | 6.3.2.1 | 0.444 | |
2a57 | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.443 | |
4rvd | SAM | D-mycarose 3-C-methyltransferase | / | 0.443 | |
4ey6 | GNT | Acetylcholinesterase | 3.1.1.7 | 0.442 | |
4r5w | XAV | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.442 | |
3elb | C5P | Ethanolamine-phosphate cytidylyltransferase | 2.7.7.14 | 0.441 | |
1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.440 | |
1h6c | NDP | Glucose--fructose oxidoreductase | 1.1.99.28 | 0.440 | |
1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | 1.2.4.1 | 0.440 | |
1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | 1.2.4.1 | 0.440 | |
2zs9 | ADP | Pantothenate kinase | 2.7.1.33 | 0.440 | |
3ggs | 2FD | Purine nucleoside phosphorylase | 2.4.2.1 | 0.440 | |
4bzb | DGT | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 3.1.5 | 0.440 | |
4ms1 | 381 | Gamma-aminobutyric acid type B receptor subunit 1 | / | 0.440 |